IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis

Psoriasis is an immune-mediated skin disorder associated with severe systemic comorbidities. Whereas IL-36 is a key disease driver, the pathogenic role of this cytokine has mainly been investigated in skin. Thus, its effects on systemic immunity and extracutaneous disease manifestations remain poorl...

Descripción completa

Detalles Bibliográficos
Autores principales: Catapano, Marika, Vergnano, Marta, Romano, Marco, Mahil, Satveer K., Choon, Siew-Eng, Burden, A. David, Young, Helen S., Carr, Ian M., Lachmann, Helen J., Lombardi, Giovanna, Smith, Catherine H., Ciccarelli, Francesca D., Barker, Jonathan N., Capon, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097848/
https://www.ncbi.nlm.nih.gov/pubmed/31539532
http://dx.doi.org/10.1016/j.jid.2019.08.444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097848/
https://www.ncbi.nlm.nih.gov/pubmed/31539532
http://dx.doi.org/10.1016/j.jid.2019.08.444

Ejemplares similares